首页> 外国专利> THERAPEUTIC EFFICACY POTENTIATOR FOR ACUTE PROMYELOCYTIC LEUKEMIA OF RETINOID CONTAINING 2'-METHYLIDENENUCLEOSIDE

THERAPEUTIC EFFICACY POTENTIATOR FOR ACUTE PROMYELOCYTIC LEUKEMIA OF RETINOID CONTAINING 2'-METHYLIDENENUCLEOSIDE

机译:包含2'-甲基核苷的类视黄醇的急性早幼粒细胞白血病的治疗功效增效剂

摘要

PROBLEM TO BE SOLVED: To obtain the subject medicament capable of synergistically potentiating the therapeutic effect of retinoid against acute promyelocyctic leukemia through its combined use with a retinoid, by including a methylidenenucleoside as an active ingredient. ;SOLUTION: This medicament is obtained by including a 2'- methylidenenucleoside which is pref. 2'-deoxy-2'-methylidenecytidine,2'-deoxy-5- fluoro-2'-methylidenecytidine or the like, or a pharmaceutically permissible acid addition salt thereof, as active ingredient. A retinoid capable of potentiating the therapeutic effect is pref. all-trans-retinoic acid or the like. The molar ratio of the above-mentioned 2'-deoxy-2'-methylidenenucleoside or pharmaceutically permissible acid addition salt thereof to the above-mentioned retinoid is pref. around 0.1-10 calculated as the 2'-methylidenenucleoside. The daily dose of this medicament as an active ingredient is preferably about 1-500 mg/kg per adult.;COPYRIGHT: (C)2000,JPO
机译:要解决的问题:通过包含甲叉基核苷作为活性成分,通过与类维生素A并用,获得能够协同增强类维生素A对急性早幼粒细胞白血病的治疗作用的主题药物。 ;解决方案:该药物是通过加入2'-亚甲基核苷制成的。作为活性成分的2′-脱氧-2′-亚甲基胞苷,2′-脱氧-5-氟-2′-亚甲基胞苷等或其药学上允许的酸加成盐。能够增强治疗效果的类维生素A是优选的。全反式视黄酸等。上述2'-脱氧-2'-亚甲基核苷或其药学上允许的酸加成盐与上述类维生素A的摩尔比为优选。以2'-亚甲基核苷计算约为0.1-10。该药物作为有效成分的日剂量优选为每位成人约1-500 mg / kg 。;版权所有:(C)2000,JPO

著录项

  • 公开/公告号JP2000327577A

    专利类型

  • 公开/公告日2000-11-28

    原文格式PDF

  • 申请/专利权人 MATSUDA AKIRA;

    申请/专利号JP19990136962

  • 发明设计人 MATSUDA AKIRA;NIITSU NOZOMI;

    申请日1999-05-18

  • 分类号A61K31/7068;A61P35/02;A61P43/00;A61K31/07;A61K45/00;

  • 国家 JP

  • 入库时间 2022-08-22 01:27:26

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号